|
1) Howlet JG, Mckelvie RS, Arnold JM, et al. Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: Diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol. 2009; 25: 85-139
|
|
|
|
2) Lahm T, McCaslin CA, Wozniak TC, et al. Medical and surgical treatment of acute right ventricular failure. J Am Coll Cardiol. 2010; 56: 1435–46
|
|
|
|
|
|
3) Gao Y, Du X, Liang L, et al. Evaluation of right ventricular function by 64-row CT in patients with chronic obstructive pulmonary disease and cor pulmonale. Eur J Radiol. 2010; [Epub ahead of print]
|
|
|
|
|
|
4) Pérez-Calvo JI, Sanchez-Marteles M, Ruiz-Ruiz F-J, et al. Differential prognostic utility of NTproBNP and Cystatin C in patients with acute exacerbation of chronic pulmonary disease. JRSM. 2010; 103: 513
|
|
|
|
|
|
5) Watz H, Waschki B, Meyer T, et al. Decreasing cardiac chamber sizes and associated heart dysfunction in COPD. Role of hyperinflation. Chest. 2010; 138: 32-8
|
|
|
|
|
|
6) Gao Y, Du X, Qin W, et al. Assessment of the right ventricular function in patients with chronic obstructive pulmonary disease using MR. Acta Radiologica. 2011; 52: 711–5
|
|
|
|
|
|
7) Miniati M, Monti S, Basta G, et al. Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study. Respir Res. 2011; 12: 37
|
|
|
|
|